CORRIGENDUM: Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients
Circulation Reports · 10.11.2026 · 8 (11) · 1930-1931
DOI: 10.1253/circrep.cr-66-0024 ↗Kurz gefasst
Korrektur in der Zeitschrift Circulation Reports, erschienen am 10.11.2026. Verfasst von Yuichi Baba und 5 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
[This corrects the article DOI: 10.1253/circrep.CR-25-0181.].
Zitieren
APA
Baba, Y., Ochi, Y., Kubo, T., Kawaguchi, J., Yamasaki, N., & Kitaoka, H. (2026). CORRIGENDUM: Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients. Circulation Reports, 8(11), 1930-1931. https://doi.org/10.1253/circrep.cr-66-0024
Vancouver
Baba Y, Ochi Y, Kubo T, Kawaguchi J, Yamasaki N, Kitaoka H. CORRIGENDUM: Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients. Circulation Reports. 2026;8(11):1930-1931. doi:10.1253/circrep.cr-66-0024
BibTeX
@article{Baba2026,
author = {Baba, Yuichi and Ochi, Yuri and Kubo, Toru and Kawaguchi, Juri and Yamasaki, Naohito and Kitaoka, Hiroaki},
title = {CORRIGENDUM: Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients},
journal = {Circulation Reports},
year = {2026},
volume = {8},
number = {11},
pages = {1930--1931},
doi = {10.1253/circrep.cr-66-0024}
}
EUVIMED